ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Ginkgo Bioworks Holdings, Inc. (DNA) stock declined over -4.18%, trading at $6.65 on NYSE, down from the previous close of $6.94. The stock opened at $7.23, fluctuating between $6.62 and $7.34 in the recent session.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Employees | 834 |
Beta | 1.24 |
Sales or Revenue | $251.46M |
5Y Sales Change% | 140.776% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |